Home A randomized controlled study of biochemical tests in primary care: interventions can reduce the number of tests but usage does not become more appropriate
Article
Licensed
Unlicensed Requires Authentication

A randomized controlled study of biochemical tests in primary care: interventions can reduce the number of tests but usage does not become more appropriate

  • Serena Lillo ORCID logo EMAIL logo , Trine Rennebod Larsen , Leif Pennerup , Kirsten Ohm Kyvik , Jens Søndergaard and Steen Antonsen
Published/Copyright: December 16, 2021

Abstract

Objectives

The use of laboratory tests increases worldwide, and to some extent their use is likely to be inappropriate. Although primary care is responsible for a substantial proportion of requests, this sector is less extensively investigated than hospitals.

Methods

We tested the effect of six combinations of four interventions applied to 313 primary care clinics, using vitamin D as model test (253,762 vitamin D results). We evaluated the changes in test numbers in the six intervention groups compared to the control group, and whether interventions resulted in more homogenous test use within groups or affected the distribution of test results. All interventions included information on vitamin D testing guidelines. Four groups were exposed to a non-interruptive alert in the ordering IT-system and in two groups this was supplemented by an interruptive alert. Half of the groups received monthly feedback reports.

Results

Application of alerts, irrespective of the combination with feedback reports, resulted in significantly reduced test numbers (maximum −46%). Guidelines either alone or combined with feedback reports did not cause significant difference from the control group. The within-group requesting pattern changed significantly for only two of the groups. The distribution of low and normal vitamin D results within groups showed no signs of more appropriate use of the test in any of the groups.

Conclusions

Some of the interventions reduced the number of tests, but there were no indications of improved adherence to the guidelines. The interventions may have led to under-utilization of the test and thus should be used with care.


Corresponding author: Serena Lillo, MSc, Biochemistry Department, Odense University Hospital (OUH) and Svendborg Hospital, Baagøes Alle 15, 5700 Svendborg, Denmark; and Department of Clinical Research, University of Southern Denmark, J.B. Winsløws Vej 19, 5000 Odense C, Denmark, E-mail:

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission. The author TRL changed job position during the study period.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: Due to being a “quality study”, an Ethical Committee permission was not required.

References

1. Cadamuro, J, Ibarz, M, Cornes, M, Nybo, M, Haschke-Becher, E, von Meyer, A, et al.. Managing inappropriate utilization of laboratory resources. Diagnosis (Berl) 2018;26:5–13.10.1515/dx-2018-0029Search in Google Scholar PubMed

2. Yeh, DD. A clinician’s perspective on laboratory utilization management. Clin Chim Acta 2014;427:145–50. https://doi.org/10.1016/j.cca.2013.09.023.Search in Google Scholar PubMed

3. Zhi, M, Ding, EL, Theisen-Toupal, J, Whelan, J, Arnaout, R. The landscape of inappropriate laboratory testing: a 15-year meta-analysis. PLoS ONE 2013;8:e78962. https://doi.org/10.1371/journal.pone.0078962.Search in Google Scholar PubMed PubMed Central

4. Huck, A, Lewandrowski, K. Utilization management in the clinical laboratory: an introduction and overview of the literature. Clin Chim Acta 2014;427:111–7. https://doi.org/10.1016/j.cca.2013.09.021.Search in Google Scholar PubMed

5. Freedman, DB. Towards better test utilization – strategies to improve physician ordering and their impact on patient outcomes. EJIFCC 2015;26:15–30.Search in Google Scholar

6. Lillo, S, Larsen, TR, Pennerup, L, Antonsen, S. The impact of interventions applied in primary care to optimize the use of laboratory tests: a systematic review. Clin Chem Lab Med 2021;59:1336–52. https://doi.org/10.1515/cclm-2020-1734.Search in Google Scholar PubMed

7. Kobewka, DM, Ronksley, PE, McKay, JA, Forster, AJ, Van Walraven, C. Influence of educational, audit and feedback, system based, and incentive and penalty interventions to reduce laboratory test utilization: a systematic review. Clin Chem Lab Med 2015;53:157–83. https://doi.org/10.1515/cclm-2014-0778.Search in Google Scholar PubMed

8. Bindraban, RS, Ten Berg, MJ, Naaktgeboren, CA, Kramer, MHH, Van Solinge, WW, Nanayakkara, PWB. Reducing test utilization in hospital settings: a narrative review. Ann Lab Med 2018;38:402–12. https://doi.org/10.3343/alm.2018.38.5.402.Search in Google Scholar PubMed PubMed Central

9. Christine Brot, PD. Sundhedsstyrelsens anbefalinger vedrørende forebyggelse, diagnostik og behandling af D-vitaminmangel Rationel Farmakoterapi, nr. 6; 2010. Available from: https://www.sst.dk/da/udgivelser/2010/rationel-farmakoterapi-6-2010/sundhedsstyrelsens-anbefalinger-vedroerende-forebyggelse-diagnostik-og-behandling-af-d-vitaminmangel.Search in Google Scholar

10. Available from: www.gdpr.eu.Search in Google Scholar

11. Available from: www.sundhed.dk. https://www.sundhed.dk/sundhedsfaglig/laegehaandbogen/endokrinologi/tilstande-og-sygdomme/knoglevaev-og-vitamin-d/d-vitamin-mangel/. 2021.Search in Google Scholar

12. StataCorp. Stata Statistical Software: Release 17. College Station TSL: StataCorp; 2021.Search in Google Scholar

13. Verstappen, WH, van der Weijden, T, Sijbrandij, J, Smeele, I, Hermsen, J, Grimshaw, J, et al.. Effect of a practice-based strategy on test ordering performance of primary care physicians: a randomized trial. JAMA 2003;289:2407–12. https://doi.org/10.1001/jama.289.18.2407.Search in Google Scholar PubMed

14. Camerotto, A, Pozzato, A, Truppo, V, Bedendo, S, Angiolelli, G, Lucchiari, A, et al.. The software GOELM as an innovative way of knowledge management and prescription of laboratory tests: the experience of two Local Healthcare Units (ULSS). Biochim Clin 2012;36:98–106.Search in Google Scholar

15. Munk, JK, Bathum, L, Jørgensen, HL, Lind, BS. A compulsory pop-up form reduces the number of vitamin D requests from general practitioners by 25 percent. Scand J Prim Health Care 2020;38:308–14. https://doi.org/10.1080/02813432.2020.1794399.Search in Google Scholar PubMed PubMed Central

16. Kimlin, MG. Geographic location and vitamin D synthesis. Mol Aspects Med 2008;29:453–61. https://doi.org/10.1016/j.mam.2008.08.005.Search in Google Scholar PubMed

17. Webb, AR, Kline, L, Holick, MF. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 1988;67:373–8. https://doi.org/10.1210/jcem-67-2-373.Search in Google Scholar PubMed


Supplementary Material

The online version of this article offers supplementary material (https://doi.org/10.1515/cclm-2021-1138).


Received: 2021-10-25
Accepted: 2021-12-07
Published Online: 2021-12-16
Published in Print: 2022-02-23

© 2021 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Obituary
  3. Dr Per Hyltoft Petersen: an appreciation
  4. Editorials
  5. Extrapolated normative GFR data for living kidney donation
  6. Effectiveness of interventions to improve test appropriateness
  7. Reviews
  8. The pathogenesis, epidemiology and biomarkers of susceptibility of pulmonary fibrosis in COVID-19 survivors
  9. S100B in cardiac surgery brain monitoring: friend or foe?
  10. Mini Review
  11. Blood lactate concentration in COVID-19: a systematic literature review
  12. Opinion Paper
  13. Commercial immunoassays for detection of anti-SARS-CoV-2 spike and RBD antibodies: urgent call for validation against new and highly mutated variants
  14. General Clinical Chemistry and Laboratory Medicine
  15. A randomized controlled study of biochemical tests in primary care: interventions can reduce the number of tests but usage does not become more appropriate
  16. A national surveillance program for evaluating new reagent lots in medical laboratories
  17. External quality assessment providers’ services appear to more impact the immunohaematology performance of laboratories than national regulatory and economic conditions
  18. International collaborative study to evaluate and calibrate two recombinant L chain Ferritin preparations for use as a WHO International Standard
  19. Method comparison of three serum free light chain assays on the Roche Cobas 6000 c501 chemistry analyzer
  20. Prospective urinary albumin/creatinine ratio for diagnosis, staging, and organ response assessment in renal AL amyloidosis: results from a large cohort of patients
  21. Analytical evaluation of the Nittobo Medical tartrate resistant acid phosphatase isoform 5b (TRACP-5b) EIA and comparison with IDS iSYS in different clinically defined populations
  22. Reference Values and Biological Variations
  23. Age-adapted percentiles of measured glomerular filtration in healthy individuals: extrapolation to living kidney donors over 65 years
  24. Indirectly determined hematology reference intervals for pediatric patients in Berlin and Brandenburg
  25. Hematology and Coagulation
  26. Monocyte distribution width (MDW): a useful biomarker to improve sepsis management in Emergency Department
  27. Diabetes
  28. A step towards optimal efficiency of HbA1c measurement as a first-line laboratory test: the TOP-HOLE (Towards OPtimal glycoHemOgLobin tEsting) project
  29. Labile glycated hemoglobin: an underestimated laboratory marker of short term glycemia
  30. Infectious Diseases
  31. Neutralizing antibody titers six months after Comirnaty vaccination: kinetics and comparison with SARS-CoV-2 immunoassays
  32. Letters to the Editors
  33. Molecular detection of SARS-CoV-2 eta VOI in Northern Italy: a case report
  34. Optimizing effectiveness of COVID-19 vaccination: will laboratory stewardship play a role?
  35. Measurement in different sample types may aid in detecting interferences and macrocomplexes affecting cardiac troponin measurements
  36. Which method to detect macrotroponin?
  37. Marked geographical variation in the prevalence of macroprolactinemia
  38. Pancreatic lipase assays: time for a change towards immunoassays?
  39. Analytical evaluation of the performances of a new procalcitonin immunoassay
  40. Necessity of harmonization of tissue transglutaminase IgA assays to align clinical decision making in coeliac disease
  41. A fortuitous but characteristic blood smear observation allowing a late diagnosis of MPS-VII
  42. Prognostic significance of blood-based multi-cancer detection in plasma cell-free DNA
Downloaded on 5.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2021-1138/html
Scroll to top button